Close Menu

Beth Israel Deaconess

The grant recipients will receive up to $5 million each and are led by scientists at institutions including Harvard Medical School and the Cleveland Clinic.

The Singapore-based firm has established a US subsidiary and named distributors to sell its products across Europe, the Middle East, and Asia.

The company is preparing a blood-based test for early-stage pancreatic cancer that it hopes to have on the market by 2019.